Generic Name: Venlafaxine
Novo-Venlafaxine XR is a Canadian brand name for the extended release form of venlafaxine. It is a selective serotonin and norepinephrine reuptake inhibitors (SSNRIs) antidepressant. It is used to treat major depressive disorder, anxiety, and panic disorder.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Treat my mood condition(s) | 3 |
|
2 | ||||
| Major Depressive Disorder | 1 |
|
1 | ||||
| Anxiety attacks | 1 | 0 | |||||
| Other | 1 | 0 |
Mouse over the table for more information
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
1 | 50% |
|
|
Doctor's advice
|
1 | 50% |
|
|
Other
|
1 | 50% |
|
|
Course of treatment ended
|
1 | 50% |
|
See all 2 patients who’ve stopped taking Novo-Venlafaxine XR
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 22, 2009.